Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

EPA:BN - Euronext Paris - Matif - FR0000120644 - Common Stock - Currency: EUR

67.52  -0.36 (-0.53%)

Fundamental Rating

5

Overall BN gets a fundamental rating of 5 out of 10. We evaluated BN against 57 industry peers in the Food Products industry. BN has an excellent profitability rating, but there are concerns on its financial health. While showing a medium growth rate, BN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
BN had a positive operating cash flow in the past year.
In the past 5 years BN has always been profitable.
BN had a positive operating cash flow in each of the past 5 years.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

BN has a Return On Assets of 4.46%. This is in the better half of the industry: BN outperforms 64.91% of its industry peers.
BN's Return On Equity of 11.34% is fine compared to the rest of the industry. BN outperforms 66.67% of its industry peers.
BN's Return On Invested Capital of 6.58% is fine compared to the rest of the industry. BN outperforms 61.40% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BN is in line with the industry average of 6.98%.
The last Return On Invested Capital (6.58%) for BN is above the 3 year average (6.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROIC 6.58%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 7.37%, BN is doing good in the industry, outperforming 73.68% of the companies in the same industry.
BN's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 13.00%, BN is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
In the last couple of years the Operating Margin of BN has declined.
The Gross Margin of BN (49.70%) is better than 73.68% of its industry peers.
In the last couple of years the Gross Margin of BN has remained more or less at the same level.
Industry RankSector Rank
OM 13%
PM (TTM) 7.37%
GM 49.7%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BN is creating some value.
The number of shares outstanding for BN has been increased compared to 1 year ago.
Compared to 5 years ago, BN has less shares outstanding
The debt/assets ratio for BN has been reduced compared to a year ago.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.37 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.37, BN perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
BN has a debt to FCF ratio of 4.89. This is a neutral value as BN would need 4.89 years to pay back of all of its debts.
The Debt to FCF ratio of BN (4.89) is better than 73.68% of its industry peers.
BN has a Debt/Equity ratio of 0.66. This is a neutral value indicating BN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, BN perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Altman-Z 2.37
ROIC/WACC1.07
WACC6.14%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.93 indicates that BN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, BN is doing worse than 73.68% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that BN may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, BN is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.77
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.54%.
Measured over the past years, BN shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.17% on average per year.
BN shows a decrease in Revenue. In the last year, the revenue decreased by -0.88%.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.60% yearly.
EPS 1Y (TTM)2.54%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%2.81%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%1.24%

3.2 Future

BN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.60% yearly.
BN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.05% yearly.
EPS Next Y7.96%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
EPS Next 5Y5.6%
Revenue Next Year1.76%
Revenue Next 2Y2.51%
Revenue Next 3Y2.9%
Revenue Next 5Y3.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.60, the valuation of BN can be described as rather expensive.
BN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. BN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.23, BN is valued on the expensive side.
61.40% of the companies in the same industry are cheaper than BN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.06, BN is valued rather cheaply.
Industry RankSector Rank
PE 18.6
Fwd PE 17.23
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BN is on the same level as its industry peers.
BN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.83
EV/EBITDA 10.11
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)2.34
PEG (5Y)N/A
EPS Next 2Y7.64%
EPS Next 3Y7.59%

5

5. Dividend

5.1 Amount

BN has a Yearly Dividend Yield of 3.15%. Purely for dividend investing, there may be better candidates out there.
BN's Dividend Yield is a higher than the industry average which is at 3.34.
BN's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.15%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years3
Div Non Decr Years4
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

66.80% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
BN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP66.8%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (7/16/2025, 7:00:00 PM)

67.52

-0.36 (-0.53%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners48.65%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap46.01B
Analysts72.5
Price Target76.13 (12.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.15%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP66.8%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.11%
PT rev (3m)3.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.32%
Valuation
Industry RankSector Rank
PE 18.6
Fwd PE 17.23
P/S 1.68
P/FCF 15.83
P/OCF 12.01
P/B 2.59
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)3.63
EY5.38%
EPS(NY)3.92
Fwd EY5.8%
FCF(TTM)4.27
FCFY6.32%
OCF(TTM)5.62
OCFY8.32%
SpS40.18
BVpS26.11
TBVpS-9.12
PEG (NY)2.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROCE 11.27%
ROIC 6.58%
ROICexc 8.06%
ROICexgc 68%
OM 13%
PM (TTM) 7.37%
GM 49.7%
FCFM 10.62%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexcg growth 3Y19.7%
ROICexcg growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Debt/EBITDA 2.49
Cap/Depr 79.02%
Cap/Sales 3.37%
Interest Coverage 20.69
Cash Conversion 81.04%
Profit Quality 144.05%
Current Ratio 0.93
Quick Ratio 0.77
Altman-Z 2.37
F-Score7
WACC6.14%
ROIC/WACC1.07
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)2.54%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%2.81%
EPS Next Y7.96%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
EPS Next 5Y5.6%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%1.24%
Revenue Next Year1.76%
Revenue Next 2Y2.51%
Revenue Next 3Y2.9%
Revenue Next 5Y3.05%
EBIT growth 1Y2.24%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year35.65%
EBIT Next 3Y14.25%
EBIT Next 5Y10.75%
FCF growth 1Y11.98%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y11.24%
OCF growth 3Y3.31%
OCF growth 5Y2.15%